Apigenin targets fetuin-A to ameliorate obesity-induced insulin resistance
International Journal of Biological Sciences · 2024 · 20 (5) · 1563-1577
DOI: 10.7150/ijbs.91695 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2024. Verfasst von Man-Chen Hsu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute and Department of Physiology, College of Medicine, National Taiwan University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Insulin Resistance. Die Arbeit wurde bisher 30-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Fetuin-A, a hepatokine secreted by hepatocytes, binds to insulin receptors and consequently impairs the activation of the insulin signaling pathway, leading to insulin resistance. Apigenin, a flavonoid isolated from plants, has beneficial effects on insulin resistance; however, its regulatory mechanisms are not fully understood. In the present study, we investigated the molecular mechanisms underlying the protective effects of apigenin on insulin resistance. In Huh7 cells, treatment with apigenin decreased the mRNA expression of fetuin-A by decreasing reactive oxygen species-mediated casein kinase 2α (CK2α)-nuclear factor kappa-light-chain-enhancer of activated B activation; besides, apigenin decreased the levels of CK2α-dependent fetuin-A phosphorylation and thus promoted fetuin-A degradation through the autophagic pathway, resulting in a decrease in the protein levels of fetuin-A. Moreover, apigenin prevented the formation of the fetuin-A-insulin receptor (IR) complex and thereby rescued the PA-induced impairment of the insulin signaling pathway, as evidenced by increased phosphorylation of IR substrate-1 and Akt, and translocation of glucose transporter 2 from the cytosol to the plasma membrane. Similar results were observed in the liver of HFD-fed mice treated with apigenin. Collectively, our findings revealed that apigenin ameliorates obesity-induced insulin resistance in the liver by targeting fetuin-A.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute and Department of Physiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Department of Cardiovascular Surgery, Min-Sheng General Hospital, Taoyuan, Taiwan.
- Cardiovascular Surgery, Department of Surgery, National Taiwan University Hospital and College of Medicine, Taipei 10051, Taiwan.
Zitieren
APA
Hsu, M. C., Chen, C. H., Wang, M. C., Chen, W. H., Hu, P. A., Guo, B. C., Chang, R. W., Wang, C. H., & Lee, T. S. (2024). Apigenin targets fetuin-A to ameliorate obesity-induced insulin resistance. International Journal of Biological Sciences, 20(5), 1563-1577. https://doi.org/10.7150/ijbs.91695
Vancouver
Hsu MC, Chen CH, Wang MC, Chen WH, Hu PA, Guo BC, et al. Apigenin targets fetuin-A to ameliorate obesity-induced insulin resistance. International Journal of Biological Sciences. 2024;20(5):1563-1577. doi:10.7150/ijbs.91695
BibTeX
@article{Hsu2024,
author = {Hsu, Man-Chen and Chen, Chia-Hui and Wang, Mu-Chun and Chen, Wen-Hua and Hu, Po-An and Guo, Bei-Chia and Chang, Ru-Wen and Wang, Chih-Hsien and Lee, Tzong-Shyuan},
title = {Apigenin targets fetuin-A to ameliorate obesity-induced insulin resistance},
journal = {International Journal of Biological Sciences},
year = {2024},
volume = {20},
number = {5},
pages = {1563--1577},
doi = {10.7150/ijbs.91695}
}
EUVIMED